Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention

Table 4 Variation in glucose levels and inflammatory status

	Reduced LVEF group (n = 48)	Normal LVEF group (n = 253)	P value
Pre-PCI
Diabetes, n (%)	24 (50.0%)	77 (30.4%)	0.008
Prediabetes, n (%)	0 (0.00%)	7 (2.8%)	0.520
Normoglycaemic, n (%)	24 (50.0%)	169 (66.8%)	0.026
Glucose level at admission, mmol/L	6.70 (3.14)	5.54 (1.64)	0.001
CRP, mg/L	5.23 (8.94)	1.69 (4.51)	< 0.001
Follow-up
Diabetes, n (%)	24 (50.0%)	77 (30.4%)	0.008
Prediabetes, n (%)	1 (2.1%)	10 (4.0%)	0.831
Normoglycaemic, n (%)	23 (47.9%)	166 (65.6%)	0.020
Glucose level at follow-up, mmol/L	6.12 (3.04)	5.42 (1.36)	0.001
Follow-up CRP, mg/L	1.37 (3.10)	0.97 (2.49)	0.012
Decreasing glucose level	− 0.12 (2.59)	− 0.05 (1.42)	0.944

Values are mean ± standard deviation, medians (interquartile range), or n (%)
LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; CRP, C-reactive protein

ISSN: 1471-2261